Title:
COMBINED COMPOUND CONSISTING OF MAGNESIUM CHLORIDE AND MAGNESIUM SULFATE
Document Type and Number:
Japanese Patent JP2023133314
Kind Code:
A
Abstract:
To provide a manufacturing method for using as a medicine a bound substance named "Sibresin (R)" in which magnesium chloride and magnesium sulfate are tightly bound together in water, the substance being not just a mixture, but a substance with functions beyond human comprehension, and as a result, being a strong effect against seasonal infectious diseases such as viral colds, influenza viruses, coronaviruses, and rotaviruses, particularly being a specific medicine for the intractable disease ALS, as well as having the relaxing effect on nerves and muscles shown in [0014] of the specification as a proof of the specific medicine.SOLUTION: In order to manufacture the magnesium salt combination (combined substance) of the present invention, the weight ratio of magnesium chloride to magnesium sulfate is in the range of 0.2 to 0.9, centered around 1.0:0.64. There are two examples below: ▲1▼ a method for manufacturing a pharmaceutical product by mixing magnesium chloride hexahydrate and anhydrous magnesium sulfate; and ▲2▼ a method for manufacturing a pharmaceutical product by mixing magnesium chloride hexahydrate and magnesium sulfate heptahydrate.SELECTED DRAWING: None
More Like This:
Inventors:
TORIYAMA TOMOMI
Application Number:
JP2023111771A
Publication Date:
September 22, 2023
Filing Date:
June 20, 2023
Export Citation:
Assignee:
TORIYAMA TOMOMI
International Classes:
A61K33/06; A61K9/48; A61P1/00; A61P1/10; A61P11/00; A61P11/10; A61P11/14; A61P21/00; A61P25/16; A61P27/02; A61P27/16; A61P31/12; A61P31/14; A61P31/16; A61P35/00
Previous Patent: Selective wavelength reflector
Next Patent: Heat treatment equipment and heat treatment method
Next Patent: Heat treatment equipment and heat treatment method